Oncology Nutrition Global Market Report 2024

Oncology nutrition involves the implementation of a healthy and balanced diet specifically tailored for cancer patients. Consuming the right types of food before, during, and after treatment is crucial for helping patients feel better and maintain strength. The goal of oncology nutrition is to enhance clinical outcomes in specific cancer types.

The primary categories of cancer addressed in oncology nutrition include blood cancer, breast cancer, stomach and gastrointestinal cancers, liver cancer, pancreatic cancer, and others. Stomach and gastrointestinal cancers encompass malignancies occurring in any part of the stomach. Various nutritional approaches, such as enteral nutrition and parenteral nutrition, are employed across different settings, including hospitals, homecare, specialty clinics, and other end users.

The oncology nutrition market research report is one of a series of new reports that provides oncology nutrition market statistics, including oncology nutrition industry global market size, regional shares, competitors with an oncology nutrition market share, detailed oncology nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the oncology nutrition industry. This oncology nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

The oncology nutrition market size has grown rapidly in recent years. It will grow from $1.74 billion in 2023 to $1.93 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%. The growth observed in the historical period can be attributed to factors such as an aging population, advancements in healthcare infrastructure, increased investments in research and development, a shift towards patient-centric care, and a rise in healthcare spending.

The oncology nutrition market size is expected to see strong growth in the next few years. It will grow to $2.81 billion in 2028 at a compound annual growth rate (CAGR) of 9.9%. The anticipated growth in the forecast period can be attributed to factors such as the increasing incidence of cancer, a rise in the demand for nutritional food, a global increase in clinical trials, and a growing disposable income. Key trends expected in the forecast period include the emergence of personalized nutrition, immuno-nutrition, genomic nutrition, integrative medicine, and a shift towards value-based care.

The increasing prevalence of cancer is a significant factor contributing to the anticipated growth of the oncology nutrition market. Cancer incidence, which refers to the number of new cancer cases within a specific population over a defined period, has been on the rise. Individuals undergoing cancer treatment require nutrition that meets their specific dietary needs, driving the demand for oncology nutrition products. For example, the American Cancer Society reported in January 2023 that the number of cancer cases had increased to 1,958,310 in 2023, marking a growth of 3.16% from 1,898,160 in 2021. Consequently, the escalating incidence of cancer is expected to be a driving force for the expansion of the oncology nutrition market.

The growth of the oncology nutrition market is also anticipated to be fueled by increasing investments in cancer research. Investment in cancer research involves allocating financial resources to support scientific endeavors aimed at understanding, preventing, diagnosing, and treating cancer. Heightened research funding facilitates a deeper comprehension of the intricate relationship between nutrition and cancer, leading to the development of specialized oncology nutrition products tailored to the unique dietary requirements of cancer patients. For instance, in March 2022, the Department of Health and Aged Care, a government agency based in Australia, allocated $893.5 million to enhance cancer services and outcomes. This increased investment in cancer research is expected to drive the growth of the oncology nutrition market.

Strategic partnerships have emerged as a prominent trend gaining traction in the oncology nutrition market. Organizations operating in the field of oncology nutrition are actively pursuing strategic collaborations to meet consumer demand and strengthen their market position. An example is the collaboration between NIHR Cancer and Nutrition, a UK-based cancer organization, and the World Cancer Research Fund, a UK-based non-profit association, in October 2021. This partnership focuses on providing consistent information and training on nutrition to cancer patients. Additionally, in March 2022, Hope Connections, a US-based non-profit organization, partnered with Food & Friends, a US-based oncology nutrition organization, to raise awareness about nutrition in the field of oncology.

Major companies in the oncology nutrition market are focusing on the development of personalized nutrition products to gain a competitive edge. Tality, a medical food based on personalized nutrition designed to inhibit the growth of cancer cells within a short timeframe, is one such example. Filtricine Inc., a US-based biotechnology company, introduced Tality in September 2023, utilizing personalized nutrition to target nutrients essential for cancer cells while sparing normal cells. The Tality meal plan, known as the TND diet, can be used alongside standard patient care or as a standalone treatment, with potential benefits observable in as little as four weeks, according to early results.

In March 2021, Nature’s Way, a US-based supplement company, acquired Baze for an undisclosed amount, leveraging the combined expertise of both companies to deliver innovative solutions to patients. Baze, a US-based personalized nutrition company, specializes in providing tailored nutrition solutions based on individual needs, catering to both patients and the general population.

Major companies operating in the oncology nutrition market include B. Braun Melsungen AG, Danone India, Abbott Laboratories, Nestle S.A., Hormel Foods Corporation, Meiji Holdings Co. Ltd., Pfizer Inc., Baxter International Inc., Mead Johnson Nutrition Company LLC, Fresenius Kabi AG, Auris Health Inc., Aceto Corporation, Hansen Medical Inc., FMC Corporation, Mead Johnson & Company LLC, Global Health Products Inc., Nutricia, Cambrooke Therapeutics Inc., Kate Farms Inc., Real Food Blends LLC, Abbott Nutrition, Fresenius Kabi USA LLC, Medtrition Inc., Nutra Balance Products, Nutritional Medicinals LLC, Pinnacle Foods Inc., Primus Pharmaceuticals Inc., Solace Nutrition, The Simply Good Foods Company, Unimed Pharma LLC, Vitaflo USA LLC

North America was the largest region in the oncology nutrition market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology nutrition market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the oncology nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The oncology nutrition market includes revenues earned by entities by bladder cancer, breast cancer, colorectal cancer, kidney cancer, and lung cancer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.